The Application of the PDCA Management Model in Improving the Diagnostic Accuracy of AIG

Ningbo No. 1 Hospital

Status: Not yet enrolling

Conditions: Autoimmune Gastritis

Treatments: Behavioral: PDCA training

Study type: Observational

Funder types: Other

Identifiers

NCT06557252

2024-091A-01

Details and patient eligibility

About

Autoimmune gastritis is currently relatively rare in China due to its insidious onset, diverse clinical manifestations involving multiple systems such as digestive, hematological, and nervous systems, and its association with other autoimmune diseases. It can also be complicated by hyperplastic gastric polyps, gastric neuroendocrine tumors, gastric adenocarcinoma, and other diseases, making it prone to clinical misdiagnosis. As a form of gastritis in the post-Helicobacter pylori era, its detection rate has been gradually increasing with the continuous improvement of endoscopic technology in China. Applying the PDCA cycle management in disease diagnosis can significantly improve the detection rate of the disease, benefiting patients. Through the PDCA management model, this study further enhanced gastroenterologists' understanding of this disease from various aspects, aiming to improve the clinical diagnosis of autoimmune gastritis.

Enrollment: 16 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Endoscopy center gastroenterologists in our hospital in 2024

Exclusion criteria

Doctors who withdrew from the PDCA management midway and stopped undergoing gastroscopy.

Trial design

16 participants in 2 patient groups

not received PDCA training

Description:

no intervention

PDCA training

Description:

The group of endoscopists underwent PDCA training to observe whether it ultimately improved the diagnosis rate of autoimmune gastritis.

Treatment:

Behavioral: PDCA training